An in Vitro Triple Cell Co-culture Model with Primary Cells Mimicking the Human Alveolar Epithelial Barrier
Overview
Authors
Affiliations
A triple cell co-culture model was recently established by the authors, consisting of either A549 or 16HBE14o- epithelial cells, human blood monocyte-derived macrophages and dendritic cells, which offers the possibility to study the interaction of xenobiotics with those cells. The 16HBE14o- containing co-culture model mimics the airway epithelial barrier, whereas the A549 co-cultures mimic the alveolar type II-like epithelial barrier. The goal of the present work was to establish a new triple cell co-culture model composed of primary alveolar type I-like cells isolated from human lung biopsies (hAEpC) representing a more realistic alveolar epithelial barrier wall, since type I epithelial cells cover >93% of the alveolar surface. Monocultures of A549 and 16HBE14o- were morphologically and functionally compared with the hAEpC using laser scanning microscopy, as well as transmission electron microscopy, and by determining the epithelial integrity. The triple cell co-cultures were characterized using the same methods. It could be shown that the epithelial integrity of hAEpC (mean ± SD, 1180 ± 188 Ω cm(2)) was higher than in A549 (172 ± 59 Ω cm(2)) but similar to 16HBE14o- cells (1469 ± 156 Ω cm(2)). The triple cell co-culture model with hAEpC (1113 ± 30 Ω cm(2)) showed the highest integrity compared to the ones with A549 (93 ± 14 Ω cm(2)) and 16HBE14o- (558 ± 267 Ω cm(2)). The tight junction protein zonula occludens-1 in hAEpC and 16HBE14o- were more regularly expressed but not in A549. The epithelial alveolar model with hAEpC combined with two immune cells (i.e. macrophages and dendritic cells) will offer a novel and more realistic cell co-culture system to study possible cell interactions of inhaled xenobiotics and their toxic potential on the human alveolar type I epithelial wall.
Mitchell S, Meldrum K, Bateman J, Tetley T, Doak S, Clift M In Vitro Model. 2025; 3(2-3):125-137.
PMID: 39872938 PMC: 11756452. DOI: 10.1007/s44164-024-00075-2.
Applying new approach methodologies to assess next-generation tobacco and nicotine products.
Thorne D, McHugh D, Simms L, Lee K, Fujimoto H, Moses S Front Toxicol. 2024; 6:1376118.
PMID: 38938663 PMC: 11208635. DOI: 10.3389/ftox.2024.1376118.
Metz J, Hittinger M, Lehr C In Vitro Model. 2024; 1(1):29-40.
PMID: 38624975 PMC: 8688684. DOI: 10.1007/s44164-021-00003-8.
The transcriptomic signature of respiratory sensitizers using an alveolar model.
Gibb M, Liu J, Sayes C Cell Biol Toxicol. 2024; 40(1):21.
PMID: 38584208 PMC: 10999393. DOI: 10.1007/s10565-024-09860-x.
Evaluation of the Epithelial Barrier Integrity in Primary Cultures of Pig Mammary Epithelial Cells.
Bernardini C, La Mantia D, Forni M Methods Mol Biol. 2023; 2749:151-164.
PMID: 38133782 DOI: 10.1007/978-1-0716-3609-1_14.